Tibor Bakacs
Chief Scientific Officer at HepC Inc
Hepc Inc
Hep is on the way
Hungary
Biography
Dr. Bakacs has over 30 years of experience in scientific research. His present main interests are (i) the theoretical immune models challenging conventional theories and (ii) the development of viral superinfection treatment of chronic HBV and HCV hepatitis patients. Formerly, he was the Head of Immunology at the Hungarian National Institute of Oncology. He also worked on various projects including regulation of natural killer cells and bispecific monoclonal antibodies in the mouse mammary tumor virus model. Dr. Bakacs was visiting scientist at the Karolinska Institute in Stockholm, Christie Hospital in Manchester and at the National Cancer Institute in the USA. Currently, he is a consultant to the Department of Probability, Alfred Rényi Institute of Mathematics. Dr. Bakacs authored 70 scientific articles and he suggested first in the journal Vaccine and then in Lancet Inf. Dis. to examine the value of the non-pathogenic bursal disease virus superinfection treatment of decompensated viral hepatitis patients.
Research Interest
Immunology Infectious Diseases Balazs Janki
